PubMed

The quality of reporting in published cost-utility analyses, 1976-1997.

Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM.

Ann Intern Med. 2000 Jun 20;132(12):964-72.PMID: 10858180 [PubMed - indexed for MEDLINE]Related articlesFree article

Growth and quality of the cost-utility literature, 1976-2001.

Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB.

Value Health. 2005 Jan-Feb;8(1):3-9. Review.PMID: 15841889 [PubMed - indexed for MEDLINE]Related articles

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.

Griebsch I, Coast J, Brown J.

Pediatrics. 2005 May;115(5):e600-14. Review.PMID: 15867026 [PubMed - indexed for MEDLINE]Related articlesFree article

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.PMID: 11701100 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-utility analyses in orthopaedic surgery.

Brauer CA, Rosen AB, Olchanski NV, Neumann PJ.

J Bone Joint Surg Am. 2005 Jun;87(6):1253-9. Review.PMID: 15930533 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of trastuzumab as adjuvant therapy for early breast cancer: a systematic review.

Chan AL, Leung HW, Lu CL, Lin SJ.

Ann Pharmacother. 2009 Feb;43(2):296-303. Epub 2009 Feb 3. Review. Erratum in: Ann Pharmacother. 2009 Mar;43(3):551. PMID: 19193576 [PubMed - indexed for MEDLINE]Related articles

Trends in the measurement of health utilities in published cost-utility analyses.

Brauer CA, Rosen AB, Greenberg D, Neumann PJ.

Value Health. 2006 Jul-Aug;9(4):213-8.PMID: 16903990 [PubMed - indexed for MEDLINE]Related articles

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.PMID: 17999840 [PubMed - indexed for MEDLINE]Related articlesFree article

How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

Schackman BR, Gold HT, Stone PW, Neumann PJ.

Pharmacoeconomics. 2004;22(5):293-300.PMID: 15061679 [PubMed - indexed for MEDLINE]Related articles

Quality of abstracts of papers reporting original cost-effectiveness analyses.

Rosen AB, Greenberg D, Stone PW, Olchanski NV, Neumann PJ.

Med Decis Making. 2005 Jul-Aug;25(4):424-8.PMID: 16061894 [PubMed - indexed for MEDLINE]Related articles

Are methods for estimating QALYs in cost-effectiveness analyses improving?

Neumann PJ, Zinner DE, Wright JC.

Med Decis Making. 1997 Oct-Dec;17(4):402-8. Review.PMID: 9343798 [PubMed - indexed for MEDLINE]Related articles

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.PMID: 18405470 [PubMed - indexed for MEDLINE]Related articlesFree article

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.

Doan QV, Chiou CF, Dubois RW.

J Manag Care Pharm. 2006 Sep;12(7):555-69. Review.PMID: 16981801 [PubMed - indexed for MEDLINE]Related articlesFree article

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.PMID: 16545207 [PubMed - indexed for MEDLINE]Related articlesFree article

A synthesis of cost-utility analysis literature in infectious disease.

Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen AB, Neumann PJ.

Lancet Infect Dis. 2005 Jun;5(6):383-91. Review.PMID: 15919624 [PubMed - indexed for MEDLINE]Related articles

Costing and perspective in published cost-effectiveness analysis.

Neumann PJ.

Med Care. 2009 Jul;47(7 Suppl 1):S28-32.PMID: 19536023 [PubMed - indexed for MEDLINE]Related articles

The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation.

Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J.

Health Technol Assess. 2008 Jun;12(25):iii, xi-194. Review.PMID: 18513466 [PubMed - indexed for MEDLINE]Related articlesFree article

Preference-based outcome measures in cost-utility analyses. A 20-year overview.

Greenberg D, Pliskin JS.

Int J Technol Assess Health Care. 2002 Summer;18(3):461-6.PMID: 12391940 [PubMed - indexed for MEDLINE]Related articles